GMEDGlobus Medical, Inc.

$83.13

$55.1052 weeks$96.82

Price

$83.13+54%1Y

1M+10%1Y+54%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier

10/10

Value69

Quality87

Momentum60

Growth74

Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Globus Medical, Inc. (together, as applicable, with its consolidated subsidiaries, “Globus,” the “Company,” “we,” “us” or “our”), headquartered in Audubon, Pennsylvania, is a medical device company that develops and commercializes healthcare solutions whose mission is to improve the quality of life of patients with musculoskeletal disorders. Founded in 2003, Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers and physicians to advance patient care and improve efficiency.

In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR

P/E (TTM)19.4

Market Cap$10.76B

1Y Return+54%

5Y Return+0.56%

Globus Medical, Inc. (GMED) reported revenue of $760M in Q1 2026 (quarter ended March 31, 2026), up 27% from the same quarter a year earlier. That came with a gross margin of 69% and net income of $124M (16% of revenue). For the full year FY2025, revenue was $2.94B (+17% year on year) and net income $538M.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.

Medical Devices

Ranks #1 of 35 by Smart Score

Bio-Rad Laboratories, Inc.